Seeing Is Believing
Currently out of the existing stock ratings of Darren Lehrich, 1 are a SELL (7.14%), 6 are a HOLD (42.86%), 7 are a BUY (50%).
Analyst Darren Lehrich, currently employed carries an average stock price target met ratio of 87.5% that have a potential upside of 20.74% achieved within 146 days. Previously, Darren Lehrich worked at DEUTSCHE BANK.
Darren Lehrich’s has documented 22 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMED, Amedisys at 09-Jun-2015.
Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for AMED (AMEDISYS) at 6/9/2015. The price target of $41 was fulfilled within 10 days with a profit of $4.89 (13.54%) receiving and performance score of 13.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$101
$10.96 (12.17%)
$101
3 months 17 days ago
(31-Jul-2024)
3/10 (30%)
$2.95 (3.01%)
70
Hold
$101
$10.96 (12.17%)
$101
3 months 23 days ago
(25-Jul-2024)
1/8 (12.5%)
$3.25 (3.32%)
45
Hold
7 months 22 days ago
(26-Mar-2024)
5/10 (50%)
$12.13 (9.49%)
99
Hold
$101
$10.96 (12.17%)
$84
1 years 3 months 17 days ago
(31-Jul-2023)
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
$101
$10.96 (12.17%)
$100
1 years 3 months 21 days ago
(27-Jul-2023)
0/5 (0%)
$10.5 (11.60%)
What Year was the first public recommendation made by Darren Lehrich?